Molecular and cellular mechanisms of syndecans in tissue injury and inflammation

Molecules and Cells

Volumn 24, Issue 2, 2007, Pages 153-166

  Bartlett, Allison H ^a   Hayashida, Kazutaka ^a   Park, Pyong Woo ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Chemokine; Heparan sulfate; Host defense; Infection; Microbial pathogenesis; Pneumonia; Proteoglycan; Tissue repair

Indexed keywords

CHEMOKINE; CYTOKINE; GROWTH FACTOR; HEPARAN SULFATE; PROTEINASE; PROTEOGLYCAN; SCLEROPROTEIN; SYNDECAN; SYNDECAN 1; SYNDECAN 2; SYNDECAN 4;

CELL ADHESION; CELL FUNCTION; CELL SURFACE; ENTERITIS; EXTRACELLULAR MATRIX; HEART INFARCTION; HOMEOSTASIS; HUMAN; IN VIVO STUDY; INFECTION; INFECTIOUS PNEUMONIA; INFLAMMATION; INFLAMMATORY DISEASE; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MODULATION; MOLECULAR DYNAMICS; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOGLYCAN SYNTHESIS; SHORT SURVEY; TISSUE INJURY;

ANIMALS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; INFECTION; INFLAMMATION; PROTEIN STRUCTURE, TERTIARY; SYNDECANS;

EID: 36549089044     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (145)

1. Alexander, C. M., Reichsman, F., Hinkes, M. T., Lincecum, J., Becker, K. A., et al. (2000) Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat. Genet. 25, 329-332.
2. Alexopoulou, A. N., Multhaupt, H. A., and Couchman, J. R. (2007) Syndecans in wound healing, inflammation and vascular biology. Int. J. Biochem. Cell Biol. 39, 505-528.
3. Andrian, E., Grenier, D., and Rouabhia, M. (2005) Porphyromonas gingivalis lipopolysaccharide induces shedding of syndecan-1 expressed by gingival epithelial cells. J. Cell. Physiol. 204, 178-183.
4. Arribas, J. and Borroto, A. (2002) Protein ectodomain shedding. Chem. Rev. 102, 4627-4638.
5. Asundi, V. K., Erdman, R., Stahl, R. C., and Carey, D. J. (2003) Matrix metalloproteinase-dependent shedding of syndecan-3, a transmembrane heparan sulfate proteoglycan, in Schwarnn cells. J. Neurosci. Res. 73, 593-602.
6. Beauvais, D. M., Burbach, B. J., and Rapraeger, A. C. (2004) The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J. Cell Biol. 167, 171-181.
7. Bergeron, Y., Ouellet, N., Deslauriers, A. M., Simard, M., Olivier, M., et al. (1998) Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect. Immun. 66, 912-922.
8. Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., et al. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729-777.
9. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M. T., Spring, J., et al. (1992) Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8, 365-393.
10. Blobel, C. P. (2002) Functional and biochemical characterization of ADAMs and their predicted role in protein ectodomain shedding. Inflamm. Res. 51, 83-84.
11. Bobardt, M. D., Chatterji, U., Selvarajah, S., Van der Schueren, B., David, G., et al. (2007) Cell-free human immunodeficiency virus type 1 transcytosis though primary genital epithelial cells. J. Virol. 81, 395-405.
12. Bode, L., Eklund, E. A., Murch, S., and Freeze, H. H. (2005) Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1015-1023.
13. Bode, L., Murch, S., and Freeze, H. H. (2006) Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy. J. Biol. Chem. 281, 7809-7815.
14. Brule, S., Charnaux, N., Sutton, A., Ledoux, D., Chaigneau, T., et al. (2006) The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9. Glycobiology 16, 488-501.
15. Carey, D. J. (1997) Syndecans: multifunctional cell-surface coreceptors. Biochem. J. 327, 1-16.
16. Charnaux, N., Brule, S., Chaigneau, T., Saffar, L., Sutton, A., et al. (2005) RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44. Glycobiology 15, 119-130.
17. Chen, E., Hermanson, S., and Ekker, S. C. (2004a) Syndecan-2 is essential for angiogenic sprouting during zebrafish development. Blood 103, 1710-1719.
18. Chen, L., Klass, C., and Woods, A. (2004b) Syndecan-2 regulates transforming growth factor-beta signaling. J. Biol. Chem. 279, 15715-15718.
19. Chen, Y., Maguire, T., Hileman, R. E., Fromm, J. R., Esko, J. D., et al. (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3, 866-871.
20. Chen, Y., Hayashida, A., Bennett, A. E., Hollingshead, S. K., and Park, P. W. (2007) Streptococcus pneumoniae sheds syndecan-1 ectodomains through ZmpC, a metalloproteinase virulence factor. J. Biol. Chem. 282, 159-167.
21. Chung, M. C., Popova, T. G., Millis, B. A., Mukherjee, D. W., Zhou, W., et al. (2006) Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors. J. Biol. Chem. 281, 31408-31418.
22. Colgan, S. P., Parkos, C. A., McGuirk, D., Brady, H. R., Papayianni, A. A., et al. (1995) Receptors involved in carbohydrate binding modulate intestinal epithelial-neutrophil interactions. J. Biol. Chem. 270, 10531-10539.
23. Contreras, H. R., Fabre, M., Granes, F., Casaroli-Marano, R., Rocamora, N., et al. (2001) Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype. Biochem. Biophys. Res. Commun. 286, 742-751.
24. Couchman, J. R. and Woods, A. (1996) Syndecans, signaling, and cell adhesion. J. Cell. Physiol. 61, 578-584.
25. Davidson, B. L., Geerts, W. H., and Lensing, A. W. (2002) Low-dose heparin for severe sepsis. N. Engl. J. Med. 347, 1036-1037.
26. Day, R. and Forbes, A. (1999) Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease. Lancet 354, 62-65.
27. Day, R. M., Mitchell, T. J., Knight, S. C., and Forbes, A. (2003) Regulation of epithelial syndecan-1 expression by inflammatory cytokines. Cytokine 21, 224-233.
28. de Parseval, A., Bobardt, M. D., Chatterji, A., Chatterji, U., Elder, J. H., et al. (2005) A highly conserved arginine in gp 120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs. J. Biol. Chem. 280, 39493-39504.
29. Diamond, M. S., Alon, R., Parkos, C. A., Quinn, M. T., and Springer, T. A. (1995) Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18). J. Cell Biol. 130, 1473-1482.
30. Dias-Baruffi, M., Pereira-da-Silva, G., Jamur, M. C., and Roque-Barreira, M. C. (1998) Heparin potentiates in vivo neutrophil migration induced by IL-8. Glycoconj. J. 15, 523-526.
31. Ding, K., Lopez-Burks, M., Sánchez-Duran, J. A., Korc, M., and Lander, M. D. (2005) Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells. J. Cell Biol. 171, 729-738.
32. Echtermeyer, F., Streit, M., Wilcox-Adelman, S., Saoncella, S., Denhez, F., et al. (2001) Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107, R9-R14.
33. Elenius, K., Määttä A., Salmivirta, M., and Jalkanen, M. (1992) Growth factors induce 3T3 cells to express bFGF-binding syndecan. J. Biol. Chem. 267, 6435-6441.
34. Elenius, V., Götte, M., Reizes, O., Elenius, K., and Bernfield, M. (2004) Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1. J. Biol. Chem. 279, 41928-41935.
35. Endo, C., Kusachi, S., Yamamoto, K., Murakami, M., Murakami, T., et al. (1997) Time-dependent increases in syndecan-1 and fibroglycan messenger RNA expression in the infarct zone after experimentally induced myocardial infarction in rats. Coron. Artery Dis. 8, 155-161.
36. Endo, K., Takino, T., Miyamori, H., Kinsen, H., Yoshizaki, R., et al. (2003) Cleavage of syndecan-1 by membrane tpye matrix metalloproteinase-1 stimulates cell migration. J. Biol. Chem. 278, 40764-40770.
37. Esko, J. D. and Lindahl, U. (2001) Molecular diversity of heparan sulfate. J. Clin. Invest. 108, 169-173.
38. Esko, J. D. and Selleck, S. B. (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71, 435-471.
39. Essner, J. J., Chen, E., and Ekker, S. C. (2006) Syndecan-2. Int. J. Biochem. Cell Biol. 38, 152-156.
40. Evans, R. C., Wong, V. S, Morris, A. L, and Rhodes, J. M. (1997) Treatment of corticosteroid-resistant ulcerative colitis with heparin-a report of 16 cases. Aliment. Pharmacol. Ther. 11, 1037-1040.
41. Fears, C. Y. and Woods, A. (2006) The role of syndecans in disease and wound healing. Matrix Biol. 25, 443-456.
42. Fears, C. Y., Gladson, C. L., and Woods, A. (2006) Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microasoular endothelial cells. J. Biol. Chem. 281, 14533-14536.
43. Finsen, A. V., Woldbaek, P. R., Li, J., Wu, J., Lyberg, T., et al. (2004) Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling. Physiol. Genomics 16, 301-308.
44. Fitzgerald, M. L., Wang, Z., Park, P. W., Murphy, GL, and Bernfield, M. (2000) Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3 sensitive metalloproteinase. J. Cell Biol. 148, 81-824.
45. HSPG-expressing Neisseria gonorrhoeae into epithelial cells. Cell. Microbiol. 2, 69-82.
46. Gaffhey, P. R., Doyle, C. T., Gaffney, A., Hogan, J., Hayes, D. P., et al. (1995) Paradoxical response to heparin in 10 patients with ulcerative colitis. Am. J Gastroenterol. 90, 220-223.
47. Gaffney, P. R., O'Leary, J. J., Doyle, C. T., Gaffney, A., Hogan, J., et al. (1991) Response to heparin in patients with ulcerative colitis. Lancet 337, 238-239.
48. Gallagher, J. T. (2001) Heparan sulfate: growth control with a restricted sequence menu. J. Clin. Invest. 108, 357-361.
49. Gallay, P. (2004) Syndecans and HIV-1 pathogenesis. Microbes. Infect. 6, 617-622.
50. Garton, K. J., Gough, P. J., and Raines, E. W. (2006) Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J. Leukoc. Biol. 79, 1105-1116.
51. Gengrinovitch, S., Berman, B., David, G., Witte, L., Neufeld, G., et al. (1999) Glypican-1 is a VEGF 165 binding proteoglycan that acts as an extracellular chaperone for VEGF 165. J. Biol. Chem. 274, 10816-10822.
52. Giuffre, L., Cordey, A. S., Monai, N., Tardy, Y., Schapira, M., et al. (1997) Monocyte adhesion to activated aortic endothelium: role of L-selectin and heparan sulfate proteoglycans. J. Cell Biol. 136, 945-956.
53. Götte, M. (2003) Syndecans in inflammation. Faseb J. 17, 575-591.
54. Götte, M., Joussen, A., M., Klein, C., Andre, P., Wagner, D. D., et al. (2002) Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature. Invest. Ophthalmol. Vis. Sci. 43, 1135-1141.
55. Grassmé, H., Gulbins, E., Brenner, B., Ferlinz, K., Sandhoff, K., et al. (1997) Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell 91, 605-615.
56. HajMohammadi, S., Enjyoji, K., Princivalle, M., Christi, P., Lech, M., et al. (2003) Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis. J. Clin. Invest. 111, 989-999.
57. Halden, Y., Rek, A., Atzenhofer, W., Szilak, L., Walmig, A., et al. (2004) Interleukin-8 binds to syndecan-2 on human endothelial cells. Biochem. J. 377, 533-539.
58. Handel, T. M., Johnson, Z., Crown, S. E, Lau, E. K., and Proudfoot, A. E. (2005) Regulation of protein function by glycosaminoglycans - as exemplified by chemokines. Annu. Rev. Biochem. 74, 385-410.
59. Hayashida, K., Johnston, D. R., Goldberger, O., and Park, P. W. (2006) Syndecan-1 expression in epithelial cells is induced by TGFβ through a PKA-dependent pathway. J. Biol. Chem. 281, 24365-24374.
60. Haynes, A., Ruda, 3rd, F., Oliver, J., Hamood, A. N., Griswold, J. A., et al. (2005a) Syndecan-1 shedding contributes to Pseudomonas aeruginosa sepsis. Infect. Immun. 73, 7914-7921.
61. Haynes, A., Rumbaugh, 3rd, K. P., Park, P. W., Hamood, A. N., and Griswold, J. A. (2005b) Protamine sulfate reduces the susceptibility of thermally injured mice to Pseudomonas aeruginosa infection. J. Surg. Res. 123, 109-117.
62. Henry-Stanley, M. J., Hess, D. J., Erlandsen, S. L., and Wells, C. L. (2005) Ability of the heparan sulfate proteoglycan syndecan-1 to participate in bacterial translocation across the intestinal epithelial barrier. Shock 24, 571-576.
63. Henry-Stanley, M. J., Zhang, B., Erlandsen, S. L., and Wells, C. L. (2006) Synergistic effect of tumor necrosis factor-alpha and interferon-gamma on enterocyte shedding of syndecan-1 and associated decreases in internalization of Listeria monocytogenes and Staphylococcus aureus. Cytokine 34, 252-259.
64. Hess, D. J., Henry-Stanley, M., J.; Erlandsen, S. L., and Wells, C. J. (2006) Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium. Med. Microbiol. Immunol. 195, 133-141.
65. Hoogewerf, A. J., Kuschert, G. S. V., Proudfoot, A. E., L., Borlat, F., Clark-Lewis, I., et al. (1997) Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36, 13570-13578.
66. Ishiguro, K., Kadomatsu, K., Kojima, T., Muramatsu, H., Iwase, M., et al. (2001a) Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice. J. Biol. Chem. 276, 47483-47488.
67. Ishiguro, K., Kadomatsu, K., Kojima, T., Muramatsu, H., Matsuo, S., et al. (2001b) Syndecan-4 deficiency increases susceptibility to kappa-carrageenan-induced renal damage. Lab. Invest. 81, 509-516.
68. Ishiguro, K., Kadomatsu, K., Kojima, T., Muramatsu, H., Nakamura, E., et al. (2000a) Syndecan-4 deficiency impairs the fetal vessels in the placental labyrinth. Dev. Dyn. 219, 539-544.
69. Ishiguro, K., Kadomatsu, K., Kojima, T., Muramatsu, H., Tsuzuki, S., et al. (2000b) Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions. J. Biol. Chem. 275, 5249-5252.
70. Jalkanen, M., Rapraeger, A., Saunders, S., and Bernfield, M. (1987) Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain. J Cell Biol. 105, 3087-3096.
71. Johnson, Z., Kosco-Vilbois, M., H., Herren, S., Cirillo, R., Muzio, V., et al. (2004) Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J Immunol. 173, 5776-5785.
72. Kaksonen, M., Pavlov, I., Voikar, V., Lauri, S. E., Hienola, A., et al. (2002) Syndecan-3-deficient mice exhibit enhanced LTP and impaired hippocampus-dependent memory. Mol. Cell Neurosci. 21, 158-172.
73. Kato, M., Saunders, S., Nguyen, H., and Bernfield, M. (1995) Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol. Biol. Cell. 6, 559-576.
74. Kerr, A. R., Irvine, J. J., Search, J. J., Gingles, N. A., Kadioglu, A., et al. (2002) Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection. Infect. Immun. 70, 1547-1557.
75. Kim, C. W., Goldberger, O. A., Gallo, R. L., and Bernfield, M. (1994) Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol. Biol. Cell. 5, 797-805.
76. Kim, H. R., Choi, M. S., and Kim, I. S. (2004) Role of syndecan-4 in the cellular invasion of Orientia tsutsugamushi. Microb. Pathog. 36, 219-225.
77. Kojima, T., Takagi, A., Maeda, M., Segawa, T., Shimizu, A., et al. (2001) Plasma levels of syndecan-4 (ryudocan) are elevated in patients with acute myocardial infarction. Thromb. Haemost. 85, 793-799.
78. Kuschert, G. S. V., Coulin, F., Power, C. A., Proudfoot, A. E. I., Hubbard, R. E., et al. (1999) Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38, 12959-12968.
79. Labandeira-Rey, M., Couzon, F., Boisset, S., Brown, E. L., Bes, M., et al. (2007) Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315, 1130-1133.
80. Langford, J. K., Yang, Y., Kieber-Emmons, T., and Sanderson, R. D. (2005) Identification of an invasion regulatory domain within the core protein of syndecan-1. J. Biol. Chem. 280, 3467-3473.
81. Li, Q., Park, P. W., Wilson, C. L., and Parks, W. C. (2002) Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111, 635-646.
82. Lind, T., Tufaro, F., McCormick, C., Lindahl, U., and Lidholt, K. (1998) The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J. Biol. Chem. 273, 26265-26268.
83. Lindahl, U., Kusche-Gullberg, M., and Kjellén, L. (1998) Regulated diversity of heparan sulfate. J. Biol. Chem. 273, 24979-24982.
84. Lortat-Jacob, H., Grosdidier, A., and Imberty, A. (2002) Structural diversity of heparan sulfate binding domains in chemokines. Proc. Natl. Acad. Sci. USA 99, 1229-1234.
85. Lowe, J. B. (2002) Glycosylation in the control of selectin counter-receptor structure and function. Immunol. Rev. 186, 19-36.
86. Ma, P., Beck, S. L., Raab, R. W., McKown, R. L., Coffman, G. L., et al. (2006) Heparanase deglycanation of syndecan-1 is required for binding of the epithelial-restricted prosecretory mitogen lacritin. J. Cell Biol. 174, 1097-1106.
87. McCormick, C., Duncan, G., Goutsos, K. T., and Tufaro, F. (2000) The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc. Natl. Acad. Sci. USA 97, 668-673.
88. Menozzi, F. D., Rouse, J. H., Alavi, M., Laude-Sharp, M., Muller, J., et al. (1996) Identification of a heparin-binding hemagglutinin present in mycobacteria. J. Exp. Med. 184, 993-1001.
89. Middleton, J., Neil, S., Wintle, J., Clark-Lewis, I., Moore, H., et al. (1997) Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91, 385-395.
90. Middleton, J., Patterson, A. M., Gardner, L., Schmutz, C., and Ashton, B. A. (2002) Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 100, 3853-3860.
91. Midwood, K. S., Valenick, L. V., Hsia, H. C., and Schwarzbauer, J. E. (2004) Coregulation of fibronectin signaling and matrix contraction by tenascin-C and syndecan-4. Mol. Biol. Cell. 15, 5670-5677.
92. Muller, W. A. (2003) Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 24, 327-334.
93. Munesue, S., Yoshitomi, Y., Kusano, Y., Koyama, Y., Nishiyama, A., et al. (2007) A novel function of syndecan-2, suppression of MMP-2 activation, which causes suppression of metastasis. J. Biol. Chem. 282, 28167-28174
94. Norgard-Sumnicht, K. E., Varki, N. M., and Varki, A. (1993) Calcium-dependent heparin-like ligands for L-selectin in nonlymphoid endothelial cells. Science 261, 480-483.
95. Ojeh, N., Hiilesvuo, K., Warri, A., Silmivirta, M., Henttinen, T., et al. (2007) Ectopic expression of syndecan-1 in basal epidermis affects keratinocyte proliferation and wound reepithelialization. J. Invest. Dermatol. (in press).
96. Ortega-Barria, E. and Pereira, M. E. (1991) A novel T. cruzi heparin-binding protein promotes fibroblast adhesion and penetration of engineered bacteria and trypanosomes into mammalian cells. Cell 67, 411-421.
97. Pancake, S. J., Holt, G. D., Mellouk, S., and Hoffman, S. L. (1992) Malaria sporozoites and circumsporozoite proteins bind specifically to sulfated glycoconjugates. J. Cell Biol. 117, 1351-1357.
98. Parish, C. R. (2006) The role of heparan sulphate in inflammation. Nat. Rev. Immunol. 6, 633-643.
99. Park, P. W., Pier, G. B., Preston, M., J., Goldberger, O., Fitzgerald, M. L., et al. (2000a) Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa. J. Biol. Chem. 275, 3057-3064.
100. Park, P. W., Reizes, O., and Bernfield, M. (2000b) Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J. Biol. Chem. 275, 29923-29926.
101. Park, P. W., Pier, G. B., Hinkes, M. T., and Bernfield, M. (2001) Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 411, 98-102.
102. Park, P. W., Foster, T. J., Nishi, E., Duncan, S. J., Klagsbrun, M., et al. (2004) Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus α-toxin and β-toxin. J. Biol. Chem. 279, 251-258.
103. Parks, W. C., Wilson, C. L., and López-Boado, Y. S. (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4, 617-629.
104. Patel, K. D., Cuvelier, S. L., and Wiehler, S. (2002) Selectins: critical mediators of leukocyte recruitment. Semin. Immunol. 14, 73-81.
105. Peiris, M. (2006) Pathogenesis of avian flu H5N1 and SARS. Novartis Found Symp. 279, 56-60.
106. Popova, T. G., Millis, B., Bradburne, C., Nazarenko, S., Bailey, C., et al. (2006) Acceleration of epithelial cell syndecan-1 shedding by anthrax hcmolytic virulence factors. BMC Microbiol. 6, 8-24.
107. Principi, M., Day, R., Marangi, S., Burattini, O., De Francesco, V., et al. (2006) Differential immunohistochemical expression of syndecan-1 and tumor necrosis factor alpha in colonic mucosa of patients with Crohn's disease. Immunopharmacol. Immunotoxicol. 28, 185-195.
108. Proudfoot, A. E., Handel, T. M., Johnson, Z., Lau, E. K., Li-Wang, P., et al. (2003) Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100, 1885-1890.
109. Rapraeger, A. and Ott, V. L. (1998) Molecular interactions of the syndecan core proteins. Curr. Opin. Cell Biol. 10, 620-628.
110. Rauch, B. H., Millette, E., Kenagy, R. D., Daum, G., Fischer, J. W., et al. (2005) Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells. J. Biol. Chem. 280, 17507-17511.
111. Reizes, O., Lincecum, J., Wang, Z., Goldberger, O., Huang, L., et al. (2001) Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell 106, 105-116.
112. Rops, A. L., Gotte, M., Baselmans, M. H., van den Hoven, M. J., Steenbergen, E. J., et al. (2007) Syndecan-1 deficiency aggravates anti-glomerular basement membrane nephritis. Kidney Int. (in press).
113. Rostand, K. S. and Esko, J. D. (1997) Microbial adherence to and invasion through proteoglycans. Infect. Immun. 65, 1-8.
114. Rot, A. and von Andrian, U. H. (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22, 891-928.
115. Sadir, R., Imberty, A., Baleux, F., and Lortat-Jacob, H. (2004) Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J. Biol. Chem. 279, 43854-43860.
116. Schmidt, A., Echtermeyer, F., Alozie, A., Brands, K., and Buddecke, E. (2005) Plasmin- and thrombin-accelerated shedding of syndecan-4 ectodomain generates cleavage sites at Lys(114)-Arg(115) and Lys(129)-Val(130) bonds. J. Biol. Chem. 280, 34441-34446.
117. Shieh, M. T., WuDunn, D., Montgomery, R. I., Esko, J. D., and Spear, P. G. (1992) Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116, 1273-1281.
118. Shukla, D. and Spear, P. G. (2001) Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 108, 503-510.
119. Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, Z., et al. (1999) A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99, 13-22.
120. Slimani, H., Charnaux, N., Mbemba, E., Saffar, L., Vassy, R., et al. (2003) Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells. Glycobiology 13, 623-634.
121. Smith, M. F., Novotony, J., Carl, V. S., and Comeau, L. D. (2006) Helicobacter pylori and toll-like receptor agonists induce syndecan-4 expression in an NF-kB-dependent manner. Glycobiology 16, 221-229.
122. Stepp, M. A., Gibson, H. E., Gala, P. H., Iglesia, D. D., Pajoohesh-Ganji, A., et al. (2002) Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse. J. Cell Sci. 115, 4517-4531.
123. Stepp, M. A., Liu, Y., Pal-Ghosh, S., Jurjus, R. A., Tadvalkar, G, et al. (2007) Reduced migration, altered matrix and enhanced TGFbeta1 signaling are signatures of mouse keratinocytes lacking Sdc1. J. Cell Sci. 120, 2851-2863.
124. Subramanian, S. V., Fitzgerald, M. L., and Bernfield, M. (1997) Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor activation. J. Biol. Chem. 272, 14713-14720.
125. Sutton, A., Friand, V., Brule-Donneger, S., Chaigneau, T., Ziol, M., et al. (2007) Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion. Mol. Cancer Res. 5, 21-33.
126. Tuomanen, E. I., Austrian, R., and Masure, H. R. (1995) Pathogenesis of pneumococcal infection. N. Engl. J. Med. 332, 1280-1284.
127. Tyrrell, D. J., Horne, A. P., Holme, K. R., Preuss, J. M., and Page, C. P. (1999) Heparin in inflammation: potential therapeutic applications beyond anticoagulation. Adv. Pharmacol. 46, 151-208.
128. Utt, M. and Wadstrom. T. (1997) Identification of heparan sulphate binding surface proteins of Helicobacter pylori: inhibition of heparan sulphate binding with sulphated carbohydrate polymers. J. Med. Microbiol. 46, 541-546.
129. Utt, M., Danielsson, B., and Wadstrom, T. (2001) Helicobacter pylori vacuolating cytotoxin binding to a putative cell surface receptor, heparan sulfate, studied by surface plasmon resonance. FEMS Immunol. Med. Microbiol. 30, 109-113.
130. van Putten, J. P. and Paul, S. M. (1995) Binding of syndecanlike cell surface proteoglycan receptors is required for Neisseria gonorrheae entry into human mucosal cells. EMBO J. 14, 2144-2154.
131. Vanhoutte, D., Schellings, M. W., Gotte, M., Swinnen, M., Herias, V., et al. (2007) Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction. Circulation 115, 475-482.
132. Vestweber, D. and Blanks, J. E. (1999) Mechanisms that regulate the function of the selectins and their ligands. Physiol. Rev. 79, 181-213.
133. Wang, L., Fuster, M., Sriramarao, P., and Esko, J. D. (2005) Endothelial heparan sulfate deficiency impairs L-selectin-and chemokine-mediated neutrophil trafficking during in flammatory responses. Nat. 1mmunol. 6, 902-910.
134. Watt, S. M., Williamson, J., Genevier, H., Fawcett, J., Simmons, D. L., et al. (1993) The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. Blood 82, 2649-2663.
135. Webb, L. M. C., Ehrengruber, M. U., Clark-Lewis, L, Baggiolini, M., and Rot, A. (1993) Binding of heparan sulfate or heparin enhances neutrophil responses to IL-8. Proc. Natl. Acad Sci. USA 90, 7158-7162.
136. Wells, T. N. and Proudfoot, A. E. (1999) Chemokine receptors and their antagonists in allergic lung disease. Inflamm. Res. 48, 353-362.
137. Westphal, V., Murch, S., Kim, S., Srikrishna, Q, Winchester, B., et al. (2000) Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation. Am. J. Pathol. 157, 1917-1925.
138. Xu, J., Park, P. W., Kheradmand, F., and Corry, D. B. (2005) Endogenous attenuation of allergic lung inflammation by syndecan-1. J. Immunol. 174, 5758-5765.
139. Yang, Y., Yaccoby, S., Liu, W., Langford, J. K., Pumphrey, C. Y., et al. (2002) Soluble syndecan-1 promotes growth of myeloma tumors in vivo. Blood 100, 610-617.
140. Yang, Y., Macleod, V., Miao, H. Q., Theus, A., Zhan, F., et al. (2007) Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. J. Biol. Chem. 282, 13326-13333.
141. Yao, Y., Rabodzey, A., and Forbes Dewey, C. Jr. (2007) Glycocalyx modulates the motility and proliferative response of vascular endothelium to fluid shear stress. Am. J. Physiol. Heart Circ. Physiol. 293, H1023-1030.
142. Yu, W. H. and Woessner, J. F. (2000) Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J. Biol. Chem. 275, 4183-4191.
143. Yu, W. H. and Woessner, J. F. Jr. (2001) Heparin-enhanced zymographic detection of matrilysin and collagenases. Anal. Biochem. 293, 38-42.
144. Zen, K. and Parkos, C. A. (2003) Leukocyte-epithelial interactions. Curr. Opin. Cell Biol. 15, 557-564.
145. Zhang, L. and Esko, J. D. (1994) Amino acid determinants that drive heparan sulfate assembly in a proteoglycan. J. Biol. Chem. 269, 19295-19299.